NHVMAS News

SAVVY trial result dissemination efforts in Lagos, Nigeria

The SAVVY trial was a phase 3 randomised controlled trail of 1% C31G Microbicides gel. The trial was to assess the effectiness of the gel to prevent HIV infection in women with high risk behaviour. The trial was conducted in two sites in Nigeria - Lagos and Ibadan. It...

read more

NHVMAS members make it to the IRMA Board

Two NHVMAS members made it into the the IRMA SC after an exhaustive process which took several months. The process resulted in the selection of 13 new members bringing the IRMA SC membership to 23.NHVMAS has a long history of  advocating for rectal microbicide...

read more

The thrill about the HPTN 035 study

The results of the HPTN 035 provide the first indication that a microbicide gel can at least partially reduce women's risk of HIV. This study represents an important step forward for HIV prevention research. Very briefly, these results are summarized as follows [as...

read more

What would the face of HIV control be in the next 25 years?

Over the next 25years, there would be increased emphasis on harnessing host factor to prevent or control HIV infection. Current approaches focus on interfering with viral attachment or replication. Future efforts would seek to harness anti-viral factors and co-factors...

read more

Like Us On Facebook